Directory
>
Joseph Higgins Md Faan
Joseph Higgins Md Faan
Chief Innovation Officer | SalioGen Therapeutics
Lexington, Massachusetts, United States
Joseph Higgins Md Faan
Summary
Joseph J. Higgins, MD, FAAN, is a distinguished leader in the field of pediatric neurology and genetics, currently serving as the Chief Innovation Officer and Co-founder of SalioGen Therapeutics. With a robust background in biochemistry and biopharmaceuticals, he has pioneered a novel, non-viral gene editing platform, securing over $160 million in funding. His extensive experience encompasses roles as a medical director and clinical development leader, notably at uniQure and Quest Diagnostics, where he advanced gene therapy trials for neurological disorders. Joseph's academic contributions include over 147 publications and teaching positions at esteemed institutions such as Harvard Medical School and Cornell University. He is board certified in Neurology with a Special Qualification in Child Neurology, reflecting his commitment to advancing pediatric healthcare. Joseph's innovative approach to medicine is underscored by his involvement in numerous clinical trials and his dedication to transforming treatment for genetic disorders in children and adults alike.
Joseph Higgins Md Faan
Work Experience
Chief Innovation Officer at
SalioGen Therapeutics
September 2023 - Present
Board Certified at
American Board of Psychiatry and Neurology, Inc.
November 1993 - Present
Board Certified at
American Board of Pediatrics (ABP)
November 1990 - Present
President, CSO, Treasurer, Board Member, Co-founder at
SalioGen Therapeutics
January 2020 - September 2023
Fellow at
American Academy of Neurology
January 2004 - January 2021
Member at
Society for Neuroscience
January 2006 - April 2020
Vice President, Clinical Development at
uniQure
March 2018 - October 2019
Medical Director, Neurology at
Quest Diagnostics
February 2012 - March 2018
Voluntary Professor at
Weill Cornell Medicine
February 2012 - January 2018
Voluntary Advisor at
American Medical Association
June 2013 - October 2014
Clinical Professor at
Weill Cornell Medicine
October 2006 - February 2012
Study Section Member at
The National Institutes of Health
January 1999 - December 2009
Executive Director, Research; Director Child Neurology at
The Institute for Family Health
September 2000 - December 2006
Director, Neurogenetics at
New York State Department of Health
January 1998 - September 2000
Associate Professor at
The State University Of New York
January 1998 - August 2000
Unit Chief, Neurogenetics at
The National Institutes of Health
July 1993 - December 1997
Assistant Professor at
George Washington University
July 1993 - December 1997
Postdoctoral Fellow, Metabolic Neurology/Neurogenetics PGY6-PGY8. at
The National Institutes of Health
July 1990 - June 1993
Resident Child Neurology PGY4, PGY5 at
George Washington University
July 1988 - June 1990
Resident Neurology PGY3 at
New York University
July 1987 - June 1988
Resident PGY2 Pediatrics at
Harvard Medical School
July 1986 - June 1987
Intern Pediatrics at
Harvard Medical School
July 1985 - June 1986
Joseph Higgins Md Faan
Education
Marist College, Bachelor Of Arts (B.A.)
January 1975 - January 1978
New York University, Doctor Of Medicine (Md)
January 1985
Frequently Asked Questions about Joseph Higgins Md Faan
What is Joseph Higgins Md Faan email address?
Joseph Higgins Md Faan's primary email address is ********@abpeds.org. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Joseph Higgins Md Faan work for?
Joseph Higgins Md Faan is a Chief Innovation Officer at SalioGen Therapeutics, a company specializing in Commercial physical research.
Where Joseph Higgins Md Faan graduated from?
Joseph Higgins Md Faan holds a degree in Biology from Marist College.
How can I directly contact Joseph Higgins Md Faan?
To contact Joseph Higgins Md Faan directly, you can use the email address ********@abpeds.org. Complete contact information is available upon registration with Muraena.
Who is Joseph Higgins Md Faan?
Joseph J. Higgins, MD, FAAN, is a distinguished leader in the field of pediatric neurology and genetics, currently serving as the Chief Innovation Officer and Co-founder of SalioGen Therapeutics. With a robust background in biochemistry and biopharmaceuticals, he has pioneered a novel, non-viral gene editing platform, securing over $160 million in funding. His extensive experience encompasses roles as a medical director and clinical development leader, notably at uniQure and Quest Diagnostics, where he advanced gene therapy trials for neurological disorders. Joseph's academic contributions include over 147 publications and teaching positions at esteemed institutions such as Harvard Medical School and Cornell University. He is board certified in Neurology with a Special Qualification in Child Neurology, reflecting his commitment to advancing pediatric healthcare. Joseph's innovative approach to medicine is underscored by his involvement in numerous clinical trials and his dedication to transforming treatment for genetic disorders in children and adults alike.
Joseph`s contact details
********@abpeds.org
*********@saliogen.com
********@abpn.com
****************@questdiagnostics.com
Colleagues
Vice President, Biomarkers and Genomics
Senior Vice President CMC, Manufacturing, Quality, and Operations
Executive Director, Platform development & Genetic engineering
Vice President Human Resources
Chief Executive Officer and Chair of Board of Directors
Head of Finance